As of 11:09 AM on the 18th, Seegene is trading at 113,300 KRW, down 4.31% from the previous day. The trading volume is 2,092,776 shares, which is about 15.77% of the previous day's volume. Seegene is known as a company that develops, manufactures, and sells molecular diagnostic reagents.

On May 14, Shin Jae-hoon, a researcher at Hanwha Investment & Securities, stated, "Seegene's first-quarter performance recorded a surprise due to the impact of COVID-19. Since the COVID-19 situation is unpredictable, estimates for future performance are cautious, but the second quarter is expected to record the highest performance ever. Reflecting the upward revision of the annual performance estimates, the target stock price is raised to 150,000 KRW."

Over the past five days, individual investors have net sold 665,265 shares of Seegene, while foreigners and institutions have net bought 18,203 shares and 623,362 shares, respectively.

※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automated article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.




This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing